Posted in | News | Renewable Energy | Wind Power

enXco Helps Los Angeles Department of Water and Power to Add 50 MW to its Clean Energy Portfolio

enXco, an EDF Energies Nouvelles Company and Southern California Public Power Authority (SCPPA), have declared the conclusion of the 50 MW Linden Wind Project.

The project conceived and formulated by enXco is owned by SCPPA. The SCPPA project that brings in CO2 free clean power to the city includes its other participating members such as City of Glendale and Los Angeles Department of Water and Power (LADWP).

The Linden Wind Farm has received the approval of SCPPA board during August 2009 and started its installation process during November 2009. The wind farm located in Klickitat County, Washington has 25 numbers of REpower manufactured MM92 wind turbines. The management of the project will be carried out by LADWP. The utility company will take delivery of nearly 90% of the produced power amounting to 45 MW from the farm. The 45 MW will represent nearly 0.5% of the utility’s proposal of achieving nearly 20% of its total power supply from renewable energy sources by the year 2010. The power produced from the wind farm will be linked to the currently available power transmission lines for delivering power to the areas of Los Angeles.

Tristan Grimbert, enXco’s President and CEO, said that the completed project depicts the rising in dynamic understanding between his company and SCPPA and its other member units. He added that his company feels elated to associate with SCPPA and in its efforts to boost its green energy sources. Bill D Carnahan, SCPPA’s Executive Director said that his institution anticipates receiving dependable renewable power from the Linden Project to augment its renewable energy power sources.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.